GlassScriptPhysician profile
Emmanuel Isang
NPI 1215347174
$7,468.85
in general payments reported to CMS, 2019-2025
38 companies · $1,198 in 2025
The $1,198 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $1,341 · 2021: $502 · 2022: $964 · 2023: $1,541 · 2024: $1,336 · 2025: $1,198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,067 · Education: $8.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,066.67 |
| Education | $8.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,313.51 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $835.13 | 2020-2024 | Xarelto |
| Amgen INC. | $766.41 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $629.00 | 2020-2023 | Optis |
| Novartis Pharmaceuticals Corporation | $568.13 | 2019-2025 | |
| Boston Scientific Corporation | $482.69 | 2022-2025 | Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $468.58 | 2019-2025 | Camzyos, Eliquis |
| Pfizer INC. | $343.10 | 2020-2025 | |
| Astrazeneca Pharmaceuticals LP | $286.46 | 2019-2025 | Farxiga, Wainua |
| Teleflex LLC | $172.93 | 2022-2025 | Guideliner, Vascband, Turnpike |
| Abiomed | $149.52 | 2020-2022 | |
| Novo Nordisk INC | $120.62 | 2022-2025 | Ozempic |
| Lantheus Medical Imaging, INC. | $115.29 | 2023 | Definity |
| Irhythm Technologies, INC. | $105.75 | 2023 | Zio Xt Patch |
| Astellas Pharma US INC | $99.99 | 2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmanuel Isang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.